Perspectives
Carve-in evidence continues to build
Linking pharmacy and medical benefits in one contract is better for the bottom line.
June 1, 2020Related news
Perspectives
August 15, 2022
September 2022 decisions expected from the FDA
At Prime Therapeutics (Prime), we’ve positioned ourselves to best prepare our clients to…
Perspectives
August 4, 2022
Specialty Pipeline Update: July 2022
This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…
Perspectives
August 4, 2022
Traditional Drug Pipeline Update: July 2022
This monthly pipeline wrap-up provides a review of newly approved traditional drugs, recent…